News & Articles

Elecsys Anti-SARS-CoV-2 S test specifically detects antibodies against the SARS- CoV-2 spike protein

Watch this on-demand webinar to find out how targeting B-cell maturation antigen and GPRC5D simultaneously could help to prevent tumor cell escape

The research helps shed light on genes responsible for a shield-like capsule that could help protect some bacteria from our immune system, making them deadly

Explore ways to improve time to result in critical pathways such as sepsis

The partnership launches RoosterBio’s first international platform with off-the-shelf working cell banks and hMSC bioprocess media products in Asia

Research Team BMP (Brain Microcircuits in Psychiatric Diseases) uncovered alterations in astrocyte metabolism as a major hallmark of depression

The agreement will accelerate the development and availability of new medical and pharmaceutical therapies to improve patients’ lives

HALIX to provide large-scale GMP manufacture of AZD1222

In a 17-4 vote, the FDA vaccine advisory committee recommended that Pfizer/BioNTech’s COVID-19 vaccine should be distributed to the U.S.

Parties to collaborate on development, commercialization, and supply of the Orgenesis therapies pipeline

Here’s what you should know when choosing the best bottles for your cell culture experiment

The kit is ideally suited to NGS library preparation from a low input, patient-derived sample types, such as nasal swabs

The new technology incorporates a 3D sensor to provide volumetric measurement to assess the integrity of a range of pharmaceutical solid dose

Designed to enrich pathologists' skills in biomarker interpretation and scoring techniques

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

Watch world-leading scientists and industry experts present the latest advances and emerging trends in biopharma, online December 8-10

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

Susie Harborth explores what it takes to be a scientist entrepreneur and highlights the technology driving innovation in bioscience

Two different dosing regimens demonstrated efficacy with one showing a better profile

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

The new lots further enhance Lonza’s renowned human primary cell offerings as it looks to meet growing market demand for deeper cell characterization

In this webinar Aaron Hineman, PerkinElmer, will review a total ICP-MS solution for your pharmaceutical impurity testing needs

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing